Status:
COMPLETED
Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs
Lead Sponsor:
Imperial College London
Conditions:
Telangiectasia, Hereditary Hemorrhagic
Eligibility:
All Genders
Brief Summary
Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an disease that leads to the development of dilated and fragile blood vessels, including arteriovenous malform...
Eligibility Criteria
Inclusion
- Patients with hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations -
Exclusion
- Unable to provide informed consent
- \-
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00230672
Start Date
March 1 2005
End Date
March 1 2008
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Hammersmith Campus
London, United Kingdom, W12 0NN